Improved Myocardial Function With Coronary Sinus Reducer in a Patient With Refractory Angina and Heart Failure With Reduced Ejection Fraction

Guglielmo Gallone; Anna Palmisano; Luca Baldetti; Caterina Beatrice Monti; Francesco Ponticelli; Giorgos Tzanis; Antonio Colombo; Antonio Esposito; Francesco Giannini

doi:10.1016/j.cjca.2019.10.030

Improved Myocardial Function With Coronary Sinus Reducer in a Patient With Refractory Angina and Heart Failure With Reduced Ejection Fraction

Guglielmo Gallone, Anna Palmisano, Luca Baldetti, Caterina Beatrice Monti, Francesco Ponticelli, Giorgos Tzanis, Antonio Colombo, Antonio Esposito, Francesco Giannini

IRCCS Ospedale San Raffaele

Research output: Contribution to journal › Article › peer-review

Abstract

The coronary sinus Reducer represents a novel therapeutic option with established safety and clinical benefit in the treatment of patients with refractory angina, possibly achieved by enhancing perfusion of myocardial ischemic territories. We report the first case providing insight on how improved perfusion might translate into improved myocardial function as assessed by cardiac magnetic resonance strain imaging, thus suggesting a physiological rationale to test coronary sinus Reducer in the setting of ischemic cardiomyopathy with reduced ejection fraction and adverse remodelling.

Original language	English
Pages (from-to)	589.e1-589.e4
Journal	Canadian Journal of Cardiology
Volume	36
Issue number	4
DOIs	https://doi.org/10.1016/j.cjca.2019.10.030
Publication status	Published - Apr 2020

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.cjca.2019.10.030

Fingerprint Dive into the research topics of 'Improved Myocardial Function With Coronary Sinus Reducer in a Patient With Refractory Angina and Heart Failure With Reduced Ejection Fraction'. Together they form a unique fingerprint.

Cite this

Gallone, G., Palmisano, A., Baldetti, L., Monti, C. B., Ponticelli, F., Tzanis, G., Colombo, A., Esposito, A., & Giannini, F. (2020). Improved Myocardial Function With Coronary Sinus Reducer in a Patient With Refractory Angina and Heart Failure With Reduced Ejection Fraction. Canadian Journal of Cardiology, 36(4), 589.e1-589.e4. https://doi.org/10.1016/j.cjca.2019.10.030

Improved Myocardial Function With Coronary Sinus Reducer in a Patient With Refractory Angina and Heart Failure With Reduced Ejection Fraction. / Gallone, Guglielmo; Palmisano, Anna; Baldetti, Luca; Monti, Caterina Beatrice; Ponticelli, Francesco; Tzanis, Giorgos; Colombo, Antonio; Esposito, Antonio; Giannini, Francesco.

In: Canadian Journal of Cardiology, Vol. 36, No. 4, 04.2020, p. 589.e1-589.e4.

Research output: Contribution to journal › Article › peer-review

Gallone, G, Palmisano, A, Baldetti, L, Monti, CB, Ponticelli, F, Tzanis, G, Colombo, A, Esposito, A & Giannini, F 2020, 'Improved Myocardial Function With Coronary Sinus Reducer in a Patient With Refractory Angina and Heart Failure With Reduced Ejection Fraction', Canadian Journal of Cardiology, vol. 36, no. 4, pp. 589.e1-589.e4. https://doi.org/10.1016/j.cjca.2019.10.030

Gallone, Guglielmo ; Palmisano, Anna ; Baldetti, Luca ; Monti, Caterina Beatrice ; Ponticelli, Francesco ; Tzanis, Giorgos ; Colombo, Antonio ; Esposito, Antonio ; Giannini, Francesco. / Improved Myocardial Function With Coronary Sinus Reducer in a Patient With Refractory Angina and Heart Failure With Reduced Ejection Fraction. In: Canadian Journal of Cardiology. 2020 ; Vol. 36, No. 4. pp. 589.e1-589.e4.

@article{621b3ff32d1f42a3a37e56bfeb0a792b,

title = "Improved Myocardial Function With Coronary Sinus Reducer in a Patient With Refractory Angina and Heart Failure With Reduced Ejection Fraction",

abstract = "The coronary sinus Reducer represents a novel therapeutic option with established safety and clinical benefit in the treatment of patients with refractory angina, possibly achieved by enhancing perfusion of myocardial ischemic territories. We report the first case providing insight on how improved perfusion might translate into improved myocardial function as assessed by cardiac magnetic resonance strain imaging, thus suggesting a physiological rationale to test coronary sinus Reducer in the setting of ischemic cardiomyopathy with reduced ejection fraction and adverse remodelling.",

author = "Guglielmo Gallone and Anna Palmisano and Luca Baldetti and Monti, {Caterina Beatrice} and Francesco Ponticelli and Giorgos Tzanis and Antonio Colombo and Antonio Esposito and Francesco Giannini",

year = "2020",

month = apr,

doi = "10.1016/j.cjca.2019.10.030",

language = "English",

volume = "36",

pages = "589.e1--589.e4",

journal = "Canadian Journal of Cardiology",

issn = "0828-282X",

publisher = "Pulsus Group Inc.",

number = "4",

}

TY - JOUR

T1 - Improved Myocardial Function With Coronary Sinus Reducer in a Patient With Refractory Angina and Heart Failure With Reduced Ejection Fraction

AU - Gallone, Guglielmo

AU - Palmisano, Anna

AU - Baldetti, Luca

AU - Monti, Caterina Beatrice

AU - Ponticelli, Francesco

AU - Tzanis, Giorgos

AU - Colombo, Antonio

AU - Esposito, Antonio

AU - Giannini, Francesco

PY - 2020/4

Y1 - 2020/4

N2 - The coronary sinus Reducer represents a novel therapeutic option with established safety and clinical benefit in the treatment of patients with refractory angina, possibly achieved by enhancing perfusion of myocardial ischemic territories. We report the first case providing insight on how improved perfusion might translate into improved myocardial function as assessed by cardiac magnetic resonance strain imaging, thus suggesting a physiological rationale to test coronary sinus Reducer in the setting of ischemic cardiomyopathy with reduced ejection fraction and adverse remodelling.

AB - The coronary sinus Reducer represents a novel therapeutic option with established safety and clinical benefit in the treatment of patients with refractory angina, possibly achieved by enhancing perfusion of myocardial ischemic territories. We report the first case providing insight on how improved perfusion might translate into improved myocardial function as assessed by cardiac magnetic resonance strain imaging, thus suggesting a physiological rationale to test coronary sinus Reducer in the setting of ischemic cardiomyopathy with reduced ejection fraction and adverse remodelling.

UR - http://www.scopus.com/inward/record.url?scp=85081029505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081029505&partnerID=8YFLogxK

U2 - 10.1016/j.cjca.2019.10.030

DO - 10.1016/j.cjca.2019.10.030

M3 - Article

C2 - 32144039

AN - SCOPUS:85081029505

VL - 36

SP - 589.e1-589.e4

JO - Canadian Journal of Cardiology

JF - Canadian Journal of Cardiology

SN - 0828-282X

IS - 4

ER -

Improved Myocardial Function With Coronary Sinus Reducer in a Patient With Refractory Angina and Heart Failure With Reduced Ejection Fraction

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this